IFP Advisors’s BioAge Labs BIOA Stock Holding History

IFP Advisors’s Portfolio BIOA Stock Details BIOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$157	Hold	9	–	–	﹤0.01%	4660
2025 Q4	$119	Buy	9 +7	+350%	+$62	﹤0.01%	4562
2025 Q3	$12	Buy	+2	New	+$9	﹤0.01%	4781

Other funds holding BIOA

ACM

AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

IFP Advisors's BIOA Position: Q1 2026 in Review

IFP Advisors held its BioAge Labs (BIOA) position steady in Q1 2026 at 9 shares worth $157. The position accounts for ﹤0.01% of the portfolio, ranked #4660.

IFP Advisors first reported a position in BIOA in Q3 2025 and has held it in 3 quarters since. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

IFP Advisors held 9 shares of BioAge Labs worth $157 as of Q1 2026.
IFP Advisors left its BioAge Labs share count unchanged in Q1 2026.
BioAge Labs made up ﹤0.01% of IFP Advisors's portfolio in Q1 2026, its #4660 holding.
IFP Advisors first reported a position in BioAge Labs in Q3 2025 and has held it in 3 quarters since.
144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on IFP Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.